Cutler Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,201
| Closed | -$610K | – | 903 |
|
|
2023
Q4 | $610K | Sell |
10,201
-26,921
| -73% | -$1.61M | 0.05% | 215 |
|
|
2023
Q3 | $1.41M | Buy |
37,122
+36,343
| +4,665% | +$1.38M | 0.14% | 120 |
|
|
2023
Q2 | $70K | Sell |
779
-2,721
| -78% | -$245K | 0.01% | 546 |
|
|
2023
Q1 | $230K | Buy |
3,500
+3,225
| +1,173% | +$212K | 0.02% | 331 |
|
|
2022
Q4 | $14K | Buy |
275
+175
| +175% | +$8.91K | ﹤0.01% | 1186 |
|
|
2022
Q3 | $6K | Sell |
100
-10,363
| -99% | -$622K | ﹤0.01% | 1482 |
|
|
2022
Q2 | $473K | Buy |
10,463
+8,200
| +362% | +$371K | 0.03% | 265 |
|
|
2022
Q1 | $114K | Sell |
2,263
-3,030
| -57% | -$153K | 0.01% | 767 |
|
|
2021
Q4 | $250K | Sell |
5,293
-96,492
| -95% | -$4.56M | 0.01% | 603 |
|
|
2021
Q3 | $3.35M | Buy |
101,785
+98,985
| +3,535% | +$3.26M | 0.15% | 95 |
|
|
2021
Q2 | $176K | Buy |
2,800
+2,000
| +250% | +$126K | 0.01% | 774 |
|
|
2021
Q1 | $34K | Buy |
800
+500
| +167% | +$21.3K | ﹤0.01% | 1290 |
|
|
2020
Q4 | $17K | Buy |
+300
| New | +$17K | ﹤0.01% | 1322 |
|
|
2020
Q3 | – | Sell |
-2,000
| Closed | -$65K | – | 1684 |
|
|
2020
Q2 | $65K | Sell |
2,000
-3,800
| -66% | -$124K | ﹤0.01% | 771 |
|
|
2020
Q1 | $155K | Buy |
+5,800
| New | +$155K | 0.01% | 496 |
|
|
2019
Q4 | – | Sell |
-2,800
| Closed | -$67K | – | 1489 |
|
|
2019
Q3 | $67K | Buy |
+2,800
| New | +$67K | 0.01% | 714 |
|